Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
intellectual property
Biotech
CRISPR patent dispute not over yet as universities appeal
Emmanuelle Charpentier, Ph.D., and two universities have officially appealed in a dispute over certain patents for CRISPR gene editing.
Annalee Armstrong
Apr 4, 2022 5:55pm
Concert tunes pipeline by selling off CNS assets to startup
Mar 11, 2022 12:30pm
Medtronic expands Type 1 diabetes reach with infusion tech buy
Sep 17, 2021 9:55am
CRISPR pioneers Doudna, Charpentier win Nobel Prize in chemistry
Oct 7, 2020 10:15am
Moderna patent case spurs concern for COVID-19 vaccine progress
Jul 24, 2020 8:50am
Daiichi sues Seattle Genetics over tech used in high-profile ADC
Nov 5, 2019 8:46am
